Because P4HA1-mediated high collagen deposition is critical in tumor microenvironment and progression, new therapeutic strategies or small molecule inhibitors are under development to target collagen synthesis for cancer therapy, which will be an important direction of cancer research in the future. This evidence concerns the gene P4HA1 and neoplasm.